Literature DB >> 19089643

Release mechanisms behind polysaccharides-based famotidine controlled release matrix tablets.

Enas M Elmowafy1, Gehanne A S Awad, Samar Mansour, Abd El-Hamid A El-Shamy.   

Abstract

Polysaccharides, which have been explored to possess gelling properties and a wide margin of safety, were used to formulate single-unit floating matrix tablets by a direct compression technique. This work has the aim to allow continuous slow release of famotidine above its site of absorption. The floating approach was achieved by the use of the low density polypropylene foam powder. Polysaccharides (kappa-carrageenan, gellan gum, xyloglucan, and pectin) and blends of polysaccharides (kappa-carrageenan and gellan gum) and cellulose ethers (hydroxypropylmethyl cellulose, hydroxypropylcellulose, sodium carboxymethyl cellulose) were tried to modulate the release characteristics. The prepared floating tablets were evaluated for their floating behavior, matrix integrity, swelling studies, in vitro drug release studies, and kinetic analysis of the release data. The differential scanning calorimetry and Fourier transform infrared spectroscopy studies revealed that changing the polymer matrix system by formulation of polymers blends resulted in formation of molecular interactions which may have implications on drug release characteristics. This was obvious from the retardation in drug release and change in its mechanistics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089643      PMCID: PMC2628252          DOI: 10.1208/s12249-008-9155-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  23 in total

1.  Stability improvement of alpha-amylase entrapped in kappa-carrageenan beads: physicochemical characterization and optimization using composite index.

Authors:  Mayur G Sankalia; Rajshree C Mashru; Jolly M Sankalia; Vijay B Sutariya
Journal:  Int J Pharm       Date:  2006-02-24       Impact factor: 5.875

2.  Mechanistic investigations of phase behavior in Eudragit E blends.

Authors:  A R Menjoge; M G Kulkarni
Journal:  Int J Pharm       Date:  2007-05-21       Impact factor: 5.875

3.  Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices.

Authors:  Kiran S Bhise; Ravindra S Dhumal; Bhaskar Chauhan; Anant Paradkar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2007-06-15       Impact factor: 3.246

4.  Analysis of surface properties of cellulose ethers and drug release from their matrix tablets.

Authors:  Baumgartner Sasa; Planinsek Odon; Srcic Stane; Kristl Julijana
Journal:  Eur J Pharm Sci       Date:  2006-01-18       Impact factor: 4.384

5.  Comparison of the polymorphic modifications of famotidine.

Authors:  B Hegedüs; P Bod; K Harsányi; I Péter; A Kálmán; L Párkányi
Journal:  J Pharm Biomed Anal       Date:  1989       Impact factor: 3.935

6.  Formulation and evaluation of famotidine floating tablets.

Authors:  M Jaimini; A C Rana; Y S Tanwar
Journal:  Curr Drug Deliv       Date:  2007-01       Impact factor: 2.565

Review 7.  Gastroretentive dosage forms: overview and special case of Helicobacter pylori.

Authors:  P L Bardonnet; V Faivre; W J Pugh; J C Piffaretti; F Falson
Journal:  J Control Release       Date:  2006-01-05       Impact factor: 9.776

8.  Drug release properties of pectinate microspheres prepared by emulsification method.

Authors:  T Wong; H Lee; L Chan; P Heng
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

9.  Intestinal clearance of H2-antagonists.

Authors:  Y F Hui; J Kolars; Z Hu; D Fleisher
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858

10.  Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery.

Authors:  Brahma N Singh; Kwon H Kim
Journal:  Int J Pharm       Date:  2007-04-08       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.